Temperature‐Controlled Radiofrequency for Severe Nasal Airway Obstruction: A Non‐Inferiority Comparison With Surgical Intervention
International Forum of Allergy & Rhinology · 2026
DOI: 10.1002/alr.70165 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Forum of Allergy & Rhinology, 2026. Verfasst von Greg Davis und 13 weiteren Autor:innen. Beteiligte Einrichtung: ENT & Allergy Associates-Proliance Surgeons, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Nasal Obstruction, Rhinoplasty, Radiofrequency Ablation, Catheter Ablation. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Temperature‐controlled radiofrequency (TCRF), septoplasty (ST) with turbinate reduction, and functional rhinoplasty (FR) are treatment options for nasal airway obstruction (NAO) and nasal valve dysfunction (NVD), but no direct comparison of these procedures has been performed.
Methods
This prospective, open‐label, non‐inferiority (NI) trial, conducted at 29 US sites, used a prespecified NI margin and inverse probability of treatment weighting to simulate randomization and facilitate an unbiased comparison of TCRF to ST and FR in adults with Nasal Obstruction Symptom Evaluation scores ≥ 55 and NVD. NI was determined using a 15% difference in the 3‐month responder rate (≥ 24‐point NOSE score improvement) for TCRF compared to ST and FR. Additional analyses included return to work/regular activities (RTW) and adverse events (AEs).
Results
A total of 174 patients were treated (116 TCRF and 58 surgery [35 ST, 23 FR]). At 3 months, TCRF was non‐inferior to surgery with a 90.5% responder rate compared to 94.3% for ST (mean difference: 0.04 [95% CI, −0.02 to 0.11]; p < 0.001) and 95.7% for FR (mean difference: −0.12 [95% CI, −0.23 to 0]; p < 0.001). TCRF median RTW was 1 day versus 5.5 and 7.5 days for ST and FR, respectively. TCRF had fewer AEs than surgery (6.9% TCRF patients vs. 19.0% for surgical arms combined).
Conclusions
TCRF patient treatment response was non‐inferior to ST and FR, with fewer AEs and faster RTW. These findings support TCRF as a minimally invasive alternative to nasal surgery for patients with NAO and NVD. Trial Registration ClinicalTrials.gov identifier: NCT06922955
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- ENT & Allergy Associates-Proliance Surgeons, Seattle, Washington, USA.
- North Florida Surgeons Advanced ENT and Allergy, Fernandina Beach, Florida, USA.
- Texas Center for Facial Plastic and Laser Surgery, San Antonio, Texas, USA.
- East Alabama ENT, Opelika, Alabama, USA.
- ExcelENT of Alabama, Birmingham, Alabama, USA.
- Breathe Clear Institute, Torrance, California, USA.
Zitieren
APA
Davis, G., Aziz, Z., Barrera, J., Blythe, W., Davis, C., Davis, S., Higgins, T., Lano, C., Levitin, G., Lopatin, F., Oyer, S., Silvers, S., Waitzman, A., & Ow, R. (2026). Temperature‐Controlled Radiofrequency for Severe Nasal Airway Obstruction: A Non‐Inferiority Comparison With Surgical Intervention. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.70165
Vancouver
Davis G, Aziz Z, Barrera J, Blythe W, Davis C, Davis S, et al. Temperature‐Controlled Radiofrequency for Severe Nasal Airway Obstruction: A Non‐Inferiority Comparison With Surgical Intervention. International Forum of Allergy & Rhinology. 2026. doi:10.1002/alr.70165
BibTeX
@article{Davis2026,
author = {Davis, Greg and Aziz, Zeeshan and Barrera, Jose and Blythe, William and Davis, Chris and Davis, Steven and Higgins, Thomas and Lano, Charles and Levitin, Gregory and Lopatin, Frederick and Oyer, Samuel and Silvers, Stacey and Waitzman, Ariel and Ow, Randall},
title = {Temperature‐Controlled Radiofrequency for Severe Nasal Airway Obstruction: A Non‐Inferiority Comparison With Surgical Intervention},
journal = {International Forum of Allergy & Rhinology},
year = {2026},
doi = {10.1002/alr.70165}
}
EUVIMED